KN-024

N/A

Report date: 2023/01/08 10:16:17

Base Information

Drug NameKN-024
Drug Alias NameKN-024
ClassificationBiologics
Mechanisms of ActionVascular endothelial growth factor inhibitors
TargetsVascular endothelial growth factor
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAlphamab Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAlphamab Co Ltd
Inactive CompaniesN/A
Active IndicationsEye Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A